The archives of the department of pathology at Women and Infants Hospital of Rhode Island, Alpert Medical School of Brown University, were searched from January 2001 through August 2008. A total of 63 ...

Endometrial cancer is the pelvic gynecological cancer with the highest incidence in the western world, affecting 24.7/100 000 women annually. 1, 2 There are currently few reliable markers to support ...

August 4, 2010 — Women with complex or atypical endometrial hyperplasia who are prescribed progestin have a 3- to 5-fold diminished risk for the development of endometrial cancer. Hysterectomy risk is ...

Please provide your email address to receive an email when new articles are posted on . Age, nulliparity, polyps and shorter sampling intervals may predict endometrial hyperplasia and cancer. Risk ...

Relative conditional survival in 41,476 patients with ovarian cancer. Oxaliplatin plus continuous infusion topotecan: An ongoing phase II study for recurrent ovarian cancer—A New York Cancer ...

Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2 We conducted a case ...

Endometrial build-up and cyclic changes are guided by ovarian hormonal signals. In a spontaneous cycle, the endometrium regenerates from the basal membrane after menstruation. This is primarily in ...

Please provide your email address to receive an email when new articles are posted on . Treatment with a levonorgestrel-dispensing intrauterine device appeared to be effective and safe for women with ...

Hormonal therapy with an intrauterine device (IUD) led to complete tumor regression in two-thirds of women with early-stage endometrial cancer or precancerous lesions, a randomized pragmatic phase II ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I have had numerous endometrial biopsies and two D and C’s.

Bayer AG ((BAYRY)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...